Simple Summary Immunotherapy has demonstrated the ability to reduce the risk of
recurrence for melanoma following surgical resection and improve survival in patients with …

Introduction: Melanoma therapies have evolved rapidly, and initial successes have
translated into survival gains for patients with advanced melanoma. Both targeted and …

Simple Summary Advanced cutaneous melanoma is the most aggressive type of skin cancer
and has variable rates of treatment response. Currently, there are some classes of …

Simple Summary Immunotherapies and molecularly targeted therapies have drastically
changed the therapeutic approach for unresectable advanced or metastatic melanoma. The …

Malignant melanoma is on the rise. There have been recent advances in targeted agents
and immunotherapies that have improved the management and treatment of patients with …

In a relatively short period of time, treatment strategies for metastatic melanoma have
radically changed leading to an unprecedented improvement in patient survival. In this …

Melanoma is responsible for nearly 9,000 deaths each year in the United States. Until the
early 2000s, chemotherapeutic agents were the mainstay of treatment for metastatic …

CME Dermatology to overcoming the immunosuppressive tumour environment and boosting
antimelanoma immunity. Overall response rates have been poor in previous studies …

Skin melanomas are malignant neoplasms originating from neuroectodermal melanocytes.
Compared to other neoplasms, melanomas have a high rate of growth. Their incidence is …

Introduction: Melanoma is an aggressive cutaneous malignancy associated with poor
response to traditional therapies. Recent regulatory approval for immune checkpoint …